Johnson & Johnson (JNJ) Receives $133.02 Consensus PT from Analysts


Shares of Johnson & Johnson have received a consensus recommendation of "Hold" from the twenty-one ratings firms that are presently covering the company, Marketbeat reports. Five analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and eight have assigned a buy recommendation to the company.



from Biotech News